Vaccines for pandemics

Nature Biotechnology

Volumn 31, Issue 11, 2013, Pages 957-960

  Schmidt, Charles ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASP 7373; AT 310; FLUNIZYN; FVH 1; HAC 1; HEMAGGLUTININ; INFLUENZA VACCINE; LAIV; NVAX; RECEPTOR; SIALIDASE; UNCLASSIFIED DRUG; VAX 125; VAXFECTIN; VIRUS ANTIGEN;

2009 H1N1 INFLUENZA; ANTIBODY RESPONSE; ARTICLE; CROSS REACTION; DNA SEQUENCE; EGG ALLERGY; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; INFLUENZA A; INFLUENZA B; INFLUENZA VIRUS; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; PRIORITY JOURNAL; VACCINE PRODUCTION; ZYGOTE;

BIOMEDICAL RESEARCH; BIOTECHNOLOGY; DRUG INDUSTRY; GENETIC ENGINEERING; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS; VIRUS CULTIVATION;

EID: 84887448153     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2733     Document Type: Article

References (6)

1. Strauss, S. Nat. Biotechnol. 28, 1227-1228 (2010).
2. Dormitzer, P.R. et al. Sci. Transl. Med. 5, 185ra68 (2013).
3. Kanekiyo, M. et al. Nature 499, 102-106 (2013).
4. Petsch, B. et al. Nat. Biotechnol. 30, 1210-1216 (2012).
5. Margine, I. et al. J. Virol. 87, 10435-10446 (2013).
6. Khurana, S. et al. Sci. Transl. Med. 5, 200ra114 (2013).